Antimicrobial peptides on the ocular surface play critical roles in fighting infections, healing wounds, and modulating immune responses — and their disruption may contribute to dry eye diseases.
Triple functionAMPs on the eye surface simultaneously fight microbes, heal wounds, and regulate immune responses — disruption of any function may contribute to dry eye
What the researchers found
Antimicrobial peptides on the ocular surface serve multiple functions including microbial defense, wound healing, and immune modulation, and their homeostasis is disrupted in dry eye disease states.
Why it matters
Dry eye affects millions of people and current treatments are limited. Understanding AMPs' protective roles could lead to peptide-based eye drops or therapies that address the root immune dysfunction, not just symptoms.
The numbers in context
AMPs: defensins, cathelicidins; roles: antimicrobial, wound healing, immune modulation; altered in dry eye
How the study worked
Narrative review of published literature on antimicrobial peptides in ocular surface health and dry eye diseases.
Who was studied
Review of AMPs in ocular surface health and dry eye diseases
What this study cannot tell us
Narrative review with no new experimental data. Most AMP research in dry eye is preclinical. Clinical translation of peptide-based eye treatments faces stability and delivery challenges.
How to read the evidence
Not applicable (narrative review). Synthesizes preclinical and observational evidence on AMPs in ocular surface health.
When this study was published
Published in 2021. Research on peptide-based eye therapies continues to advance.
The bigger picture
AMPs are being increasingly recognized for roles beyond simple antimicrobial activity. Their immune-modulatory and wound-healing functions make them promising candidates for treating inflammatory conditions of the eye, potentially replacing or complementing current anti-inflammatory therapies.
Questions still open
- Could topical AMP formulations effectively treat dry eye disease?
- Which specific antimicrobial peptides are most altered in dry eye, and do levels correlate with disease severity?
- Would AMP-based therapies complement or replace current anti-inflammatory dry eye treatments?
Common questions
What do antimicrobial peptides do in the eye?
Could peptide-based eye drops treat dry eye?
Read the original research
The Role of Endogenous Antimicrobial Peptides in Modulating Innate Immunity of the Ocular Surface in Dry Eye Diseases.
International journal of molecular sciences, 22(2)
Citation
Eshac, Youssof; Redfern, Rachel L; Aakalu, Vinay Kumar. (2021). The Role of Endogenous Antimicrobial Peptides in Modulating Innate Immunity of the Ocular Surface in Dry Eye Diseases.. International journal of molecular sciences, 22(2). https://doi.org/10.3390/ijms22020721